BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29783674)

  • 21. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.
    Roche DJ; Bujarski S; Hartwell E; Green R; Ray LA
    Pharmacol Biochem Behav; 2015 Jul; 134():92-8. PubMed ID: 25933795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Influence of Puff Characteristics, Nicotine Dependence, and Rate of Nicotine Metabolism on Daily Nicotine Exposure in African American Smokers.
    Ross KC; Dempsey DA; St Helen G; Delucchi K; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):936-43. PubMed ID: 27030603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking history, cigarette yield and smoking behavior as determinants of smoke exposure.
    Bridges RB; Humble JW; Turbek JA; Rehm SR
    Eur J Respir Dis Suppl; 1986; 146():129-37. PubMed ID: 3465542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.
    Melikian AA; Djordjevic MV; Hosey J; Zhang J; Chen S; Zang E; Muscat J; Stellman SD
    Nicotine Tob Res; 2007 Mar; 9(3):377-87. PubMed ID: 17365769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The feasibility of measuring puffing behaviour in roll-your-own cigarette smokers.
    Shahab L; West R; McNeill A
    Tob Control; 2008 Sep; 17 Suppl 1():i17-23. PubMed ID: 18768455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between negative affect and smoking topography in heavy drinking smokers.
    Green R; Bujarski S; Roche DJ; Ray LA
    Addict Behav; 2016 Oct; 61():53-7. PubMed ID: 27240211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine and carbon monoxide exposure from inhalation of cigarillo smoke.
    Koszowski B; Rosenberry ZR; Kanu A; Viray LC; Potts JL; Pickworth WB
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):7-14. PubMed ID: 26459155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group Waterpipe Tobacco Smoking Increases Smoke Toxicant Concentration.
    Ramôa CP; Shihadeh A; Salman R; Eissenberg T
    Nicotine Tob Res; 2016 May; 18(5):770-6. PubMed ID: 26659913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes.
    Lee YH; Gawron M; Goniewicz ML
    Addict Behav; 2015 Sep; 48():1-4. PubMed ID: 25930009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Reliability and Stability of Puff Topography Variables in Non-Daily Smokers Assessed in the Laboratory.
    Gass JC; Germeroth LJ; Wray JM; Tiffany ST
    Nicotine Tob Res; 2016 Apr; 18(4):484-90. PubMed ID: 25744955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking topography: reliability and validity in dependent smokers.
    Lee EM; Malson JL; Waters AJ; Moolchan ET; Pickworth WB
    Nicotine Tob Res; 2003 Oct; 5(5):673-9. PubMed ID: 14577984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First cigarette on waking and time of day as predictors of puffing behaviour in UK adult smokers.
    Grainge MJ; Shahab L; Hammond D; O'Connor RJ; McNeill A
    Drug Alcohol Depend; 2009 May; 101(3):191-5. PubMed ID: 19264427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential control of puff duration and interpuff interval in cigarette smokers.
    Chait LD; Griffiths RR
    Pharmacol Biochem Behav; 1982 Jul; 17(1):155-8. PubMed ID: 7122661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does puffing behavior alter during the smoking of a single cigarette?
    Guyatt AR; Kirkham AJ; Baldry AG; Dixon M; Cumming G
    Pharmacol Biochem Behav; 1989 May; 33(1):189-95. PubMed ID: 2780776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of puff volume to other topographical measures of smoking.
    Gust SW; Pickens RW; Pechacek TF
    Addict Behav; 1983; 8(2):115-9. PubMed ID: 6613709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers.
    Kassel JD; Greenstein JE; Evatt DP; Wardle MC; Yates MC; Veilleux JC; Eissenberg T
    J Adolesc Health; 2007 Jan; 40(1):54-60. PubMed ID: 17185206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and sequelae of smoking topography over the course of a single cigarette in adolescent light smokers.
    Veilleux JC; Kassel JD; Heinz AJ; Braun A; Wardle MC; Greenstein J; Evatt DP; Conrad M
    J Adolesc Health; 2011 Feb; 48(2):176-81. PubMed ID: 21257117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
    Bozikas VP; Niopas I; Kafantari A; Kanaze FI; Gabrieli C; Melissidis P; Gamvrula K; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):1-6. PubMed ID: 15610938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panic attack history and smoking topography.
    Farris SG; Brown LA; Goodwin RD; Zvolensky MJ
    Drug Alcohol Depend; 2017 Feb; 171():84-90. PubMed ID: 28033542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study.
    Hammond D; Fong GT; Cummings KM; Hyland A
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1370-5. PubMed ID: 15941943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.